Upgrade Now

Company Announcements

Director/PDMR Shareholding

Related Companies

By LSE RNS

RNS Number : 1712R
Dechra Pharmaceuticals PLC
19 September 2017
 



 

 

 

19 September 2017

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

 

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

 

 

 

Dechra Pharmaceuticals PLC announces that on 19 September 2017, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 15 September 2014 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which vested at 100% of the total award.

 

Name

Capacity

Options Exercised

Total beneficial shareholding following this announcement

Percentage of issued share capital

Ian Page

Director

115,334

792,142

0.848%

Tony Griffin

Director

29,937

  94,257

0.101%

 

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Ian Page

 

2.

Reason for the notification

a)

Position/status

Director/PDMR

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

N/A

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB0009633180

b)

Nature of the transaction

Exercise of 115,334 options under the Company's Long Term Incentive Plan

 

c)

Price(s) and volumes(s)

Price(s)

£Nil Cost

Volume(s)

115,334

d)

Aggregated information

-   Aggregate volume

-   Price

 

 

N/A

e)

Date of the transaction

2017.09.15

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Tony Griffin

 

2.

Reason for the notification

a)

Position/status

Director/PDMR

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB009633180

b)

Nature of the transaction

Exercise of 29,937 options under the Company's Long Term Incentive Plan

c)

Price(s) and volumes(s)

Price(s)

£nil

Volume(s)

29,937

d)

Aggregated information

-   Aggregate volume

-   Price

 

 

N/A

e)

Date of the transaction

2017.09.15

f)

Place of the transaction

Outside a trading venue

 

 

For further information, please contact:

 

Melanie Hall, Company Secretary                         

Telephone number: 01606 814730

 

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKCDBKBKDCCD

Top of Page